U.S. Pharma Stock News

AppLovin (APP) has opened 2026 with Q1 revenue of US$1.8 billion and basic EPS of US$3.57, setting the tone for its latest earnings season update. The company has seen quarterly revenue move from US$1.0 billion in Q4 2024 to US$1.2 billion in Q1 2025 and then to US$1.8 billion in Q1 2026. Basic EPS over the same points stepped from US$1.76 to US$2.13 and then to US$3.57, giving investors a clear view of scaling revenue alongside higher earnings per share as margins stay in focus. See our full...

DuPont de Nemours (DD) drew fresh attention after reporting first quarter 2026 results ahead of prior guidance, raising full year sales expectations, and detailing further share repurchases and portfolio moves following an Aramids divestiture. See our latest analysis for DuPont de Nemours. The earnings beat and higher guidance came after a strong run, with an 18.33% year to date share price return and a very large 1 year total shareholder return of 78.12%, suggesting momentum has been...

In the first quarter ended March 31, 2026, Knife River Corporation reported revenue of US$410.13 million versus US$353.47 million a year earlier, alongside a net loss of US$79.18 million, while also outlining an active acquisition pipeline across aggregates, ready-mix, asphalt, prestressed concrete and contracting businesses. Management emphasized Knife River’s reputation as an acquirer of choice, highlighting nearly 100 completed acquisitions and a disciplined, value-accretive approach...

JPMorgan Chase & Co. has disclosed a passive stake exceeding 10% of Dover Corporation’s outstanding shares. The position makes JPMorgan a major institutional shareholder in Dover Corporation (NYSE:DOV). The holding is reported as passive, indicating no stated intention to influence Dover’s corporate control. Dover Corporation, through its portfolio of industrial and technology businesses, operates within trends tied to automation, process efficiency and diversified manufacturing. A large...

Riot Platforms (NasdaqCM:RIOT) has announced a partnership with Terrestrial Energy to explore nuclear powered data centers. The collaboration focuses on using modular nuclear reactors to supply power for hyperscale data centers and high performance computing workloads. This marks a long term expansion of Riot Platforms' business model beyond Bitcoin mining and AI focused data centers. Riot Platforms is increasingly positioning itself as more than a Bitcoin miner, with the stock at $24.11...

Rackspace Technology (RXT) opened 2026 with Q1 revenue of US$678.1 million and basic EPS of US$0.03, compared to a trailing 12 month basic EPS loss of US$0.60 on revenue of US$2.7 billion. The company has seen quarterly revenue move from US$685.6 million in Q4 2024 to US$665.4 million in Q1 2025 and US$678.1 million in Q1 2026. Basic EPS shifted from a loss of US$0.25 in Q4 2024 to a loss of US$0.31 in Q1 2025 and then to a small profit in the latest quarter. This sets up a results season...

Recursion Pharmaceuticals (NasdaqGS:RXRX) reported positive early clinical milestones across several AI-driven drug programs. REC-1245 showed encouraging early safety data in humans. Patient dosing has started for REC-4539, moving another asset into active clinical testing. REC-4881 produced meaningful efficacy signals in familial adenomatous polyposis, prompting engagement with the FDA about a potential registrational path. For investors watching NasdaqGS:RXRX, these program updates focus...

Solstice Advanced Materials (SOLS) opened 2026 with Q1 revenue of US$992 million and basic EPS of US$0.54, giving investors a fresh look at its earnings power after a volatile prior year. Over recent quarters the company has seen revenue move from US$897 million in Q1 2025 to US$969 million in Q3 2025, US$987 million in Q4 2025 and now US$992 million in Q1 2026. Quarterly basic EPS has ranged from a loss of US$0.22 in Q3 2025 to US$0.84 in Q1 2025 and US$0.26 in Q4 2025 before landing at...

Investors may naturally wonder whether Nebius Group at US$184.77 is now priced for perfection or still offers room for value after such a strong run. The stock has posted returns of 33.7% over the past week, 57.4% over the past month and 105.4% year to date, with a very large 1 year gain that may have shifted how investors view both its potential and its risks. Recent coverage has focused on Nebius Group's sharp share price moves and what they might imply about sentiment toward its business...

Shareholders might have noticed that XPEL, Inc. ( NASDAQ:XPEL ) filed its quarterly result this time last week. The...

In recent months, G-III Apparel Group reported fiscal 2026 net sales of US$3.00 billion, reduced from US$3.20 billion a year earlier, while facing weaker guidance, a 33% cut to CEO Morris Goldfarb’s estimated 2026 pay, and intensified legal conflict with PVH Corp. over key brand licenses. At the same time, the company is emphasizing its strong balance sheet, over US$400 million in cash, new quarterly dividend, and a push into owned brands like DKNY and Donna Karan, even as insider share...

Morningstar and its subsidiary PitchBook recently announced a partnership with Perplexity to integrate their investment research and market intelligence directly into Perplexity’s AI platform, giving eligible users access within Perplexity and Perplexity Computer. This move highlights Morningstar’s push to embed its analyst-backed data and research into external AI-driven tools that investors and professionals already use. Next, we’ll examine how this AI integration into investor workflows...

It looks like ConocoPhillips ( NYSE:COP ) is about to go ex-dividend in the next two days. The ex-dividend date is...

Last week saw the newest quarterly earnings release from Haverty Furniture Companies, Inc. ( NYSE:HVT ), an important...

Stevanato Group (NYSE:STVN) opened 2026 with Q1 revenue of €273.6 million and basic EPS of €0.10, alongside trailing 12 month revenue of about €1.2 billion and EPS of €0.52 that frame the latest quarter against a fuller earnings backdrop. Over recent periods, revenue has ranged from €256.6 million in Q1 2025 to €346.5 million in Q4 2025, while basic EPS has moved between €0.10 and €0.17 across those quarters, giving investors a clear view of how the top and bottom lines are tracking into the...

Vishay Intertechnology (NYSE:VSH) has introduced the VCNL36758, a high sensitivity proximity sensor targeting smart home, industrial, and office uses. The device integrates an IR emitter, photodiode, amplifier, and ADC in a compact package to support presence detection, automation, and energy management applications. The launch highlights a new product focused on saving board space while broadening detection capabilities for next generation electronics. For investors tracking NYSE:VSH, this...

Curtiss-Wright (CW) opened 2026 with Q1 revenue of US$913.7 million and Basic EPS of US$3.47, while trailing twelve month revenue sat at about US$3.6 billion with EPS of US$13.73 and net income of US$511.1 million. Over the last five reported quarters, revenue has moved from US$805.6 million in Q1 2025 to US$913.7 million in Q1 2026, with Basic EPS over that span ranging between US$2.69 and US$3.71. With trailing net profit margin edging higher over the past year, these results give investors...

Primerica (PRI) opened 2026 with Q1 revenue of US$885.9 million and basic EPS of US$6.00, supported by net income of US$190.1 million and a combined ratio of 65.2%, setting a clear tone for how the year is starting. The company has seen quarterly revenue move from US$803.4 million in Q4 2024 to US$819.5 million in Q1 2025 and then to US$885.9 million in Q1 2026. Over that period, basic EPS ranged from US$4.99 to US$6.36, pointing to a business that is still generating meaningful profits as...

In the past quarter, NOV Inc. repurchased 3,500,000 shares for US$67 million, completing a broader buyback of 40,475,436 shares for US$611.23 million under its April 26, 2024 authorization, while reporting first-quarter 2026 revenue of US$2,052 million and net income of US$19 million, both lower than a year earlier. The earnings release, guidance for a 4% to 6% year-over-year revenue decline in the second quarter of 2026, and Barclays’ downgrade to Underweight despite a more positive view on...

Mueller Water Products (NYSE:MWA) has flagged a higher priority on acquisitions, with management highlighting more active work on potential targets. The company is planning to use its balance sheet and increased M&A readiness to expand its portfolio and support net sales growth. This marks a shift in capital allocation focus toward deals that could reshape its market presence and operating profile. Mueller Water Products focuses on water infrastructure products and services, an area that...

Chubb (NYSE:CB) has formed an alliance with Verified Clinical Trials to support risk management and data quality in clinical research. The partnership focuses on research subject safety, data integrity, and reducing operational and regulatory risks using VCT's subject registry technology. This development extends Chubb's activity beyond traditional insurance coverage into technology driven clinical trial risk solutions. For investors tracking Chubb at a current share price of $321.28, the...

In early May 2026, TowneBank was caught up in a broader regional bank pullback as renewed U.S.-Iran tensions drove oil prices higher and pushed Treasury yields toward nine-month highs, rekindling stagflation worries. This episode highlights how quickly the macro backdrop, especially inflation-driven moves in the yield curve, can alter perceptions of earnings resilience for regional lenders like TowneBank. We’ll now examine how this inflation-driven shift in Treasury yields may influence...

If you are wondering whether Entergy stock still offers value at recent prices, it helps to step back and look at both the recent returns and what they might be pricing in. The stock last closed at US$112.02, with a 7 day return of a 5% decline, a 30 day return of a 1.6% decline, and a gain of 19.3% year to date and 37.9% over the past year, with multi year returns that have been very large over 3 and 5 years. Recent price moves sit against a backdrop of ongoing interest in regulated...

Wondering if Intellia Therapeutics at around US$13.71 is offering value or just volatility? This article walks through what the current price may be implying about the stock. The stock has returned 1.7% over the last 7 days, 1.2% over 30 days, 48.9% year to date and 65.6% over the past year, while longer term 3 year and 5 year returns of 69.3% and 77.5% declines show how sentiment around the stock has shifted over time. Recent headlines around Intellia Therapeutics have focused on its...